ACSL4 and renal cell carcinoma: To identify the target proteins through which COP1 exerts its effects in RCC cells, we overexpressed COP1 in 786-O cells and detected binding partners via mass spectrometry and co-immunoprecipitation (Co-IP), confirming ACSL4 as a COP1 interactor (Figure 2A).